Citi Appointed as Depositary Bank for Centessa Pharmaceuticals plc’s ADR Programme
Citi has been appointed by Centessa Pharmaceuticals to serve as the depositary bank for its American Depositary Receipt (ADR) program. Centessa's American Depositary Shares (ADSs) are listed on the Nasdaq under the symbol 'CNTA'. Dirk Jones from Citi expressed enthusiasm for supporting Centessa's ADR program and enhancing investor outreach through their global equity distribution network. Centessa aims to innovate the drug development process by applying an asset-centric R&D model across its ten subsidiaries, backed by centralized infrastructure.
- Centessa's ADR program may enhance investor outreach.
- Appointment of Citi indicates confidence in the company's financial structure.
- None.
Citi, acting through Citibank N.A., has been appointed by Centessa Pharmaceuticals plc (“Centessa”), a next-generation biopharmaceutical company, to act as depositary bank for its American Depositary Receipt (“ADR”) programme.
Centessa’s American Depositary Shares (“ADSs”) trade on the Nasdaq Global Market under the symbol “CNTA”. Each ADS represents one ordinary share of the company.
Commenting on the appointment, Dirk Jones, Global Head of Issuer Services, at Citi said: “We look forward to supporting Centessa’s ADR programme and expanding the company’s investor outreach through the expertise of our Investor Relations Advisory team and the breadth of our global equity distribution network.”
For more information on Citi’s Depositary Receipt Services, please visit www.citi.com/dr
About Centessa
Centessa Pharmaceuticals plc is a next-generation biopharmaceutical company that aims to reshape the traditional drug development process. The company applies an asset-centric R&D model at scale to advance a portfolio of programs led by industry-leading teams. Each program is developed by one of ten Centessa subsidiaries and supported by centralized infrastructure and the Centessa management team.
Additional information may be found at www.centessa.com
About Citi
Citi, the leading global bank, has approximately 200 million customer accounts and does business in more than 160 countries and jurisdictions. Citi provides consumers, corporations, governments and institutions with a broad range of financial products and services, including consumer banking and credit, corporate and investment banking, securities brokerage, transaction services, and wealth management.
Additional information may be found at www.citigroup.com | Twitter: @Citi | YouTube: www.youtube.com/citi | Blog: http://blog.citigroup.com | Facebook: www.facebook.com/citi | LinkedIn: www.linkedin.com/company/citi
View source version on businesswire.com: https://www.businesswire.com/news/home/20210607005037/en/
FAQ
What is Centessa Pharmaceuticals' stock symbol?
Who has been appointed as the depositary bank for Centessa Pharmaceuticals?
How do Centessa Pharmaceuticals' American Depositary Shares trade?
